Sort
59,101 grants matching “hypertension”
Genetic and Epigenetic Mechanisms of BP Regulation
$2,309,802Mingyu Liang · University Of Arizona · P01 · FY2024 · HL
Hopkins Center for Eliminate Cardiovascular Health Disparities
$2,308,906Lisa A Cooper · Johns Hopkins University · P50 · FY2013 · HL
Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia
$2,307,686Christoph Hornik · Duke University · R33 · FY2022 · HL
GENERAL CLINICAL RESEARCH CENTER
$2,306,787University Of Texas Sw Med Ctr/Dallas · M01 · FY2001 · RR
The VETSA Longitudinal MRI Twin Study of Aging
$2,305,590William S Kremen · University Of California, San Diego · R01 · FY2016 · AG
SCOR-MOLECULAR GENETICS OF HYPERTENSION
$2,304,577University Of Iowa · P50 · FY2005 · HL
Transformed Probiotic Bacteria for Treatment of Chronic Diseases
$2,302,500Sean Stephen Davies · Vanderbilt University · DP2 · FY2007 · OD
Integrating novel mechanisms controlling sodium excretion and blood pressure
$2,302,031David M Pollock · University Of Alabama At Birmingham · P01 · FY2017 · HL
Role Of Neuropeptides And Biogenic Amines In Stress and Brain Inflammation
$2,301,252Juan M Saavedra · National Institute Of Mental Health · Z01 · FY2008 · MH
Genotyping the Understanding America Study to generate novel opportunities for research on cognitive functioning and dementia
$2,300,463Titus Johannes Galama · University Of Southern California · R01 · FY2024 · AG
A mechanistic and dyadic approach to identify how interpersonal conscientiousness supports cognitive health and lowers risk of dementia
$2,300,176Angelina R Sutin · Florida State University · RF1 · FY2023 · AG
Integrative Consequences of Hypoxia
$2,299,812Nanduri R Prabhakar · University Of Chicago · P01 · FY2008 · HL
CLINICAL PHARMACOKINETICS AND SAFETY TRIALS IN DOWN SYNDROME
$2,298,706Mara Becker · Duke University · N01 · FY2020 · HD
Environmental Influences on Child Health Outcomes (ECHO) and Pregnancy in Ohio
$2,298,159Jonathan Lee Slaughter · Research Inst Nationwide Children'S Hosp · UH3 · FY2025 · OD
Biomarkers to Track Effective Interventions that Delay Dementia Onset in Participants of the "Risk Reduction for Alzheimer's Disease (rrAD)" Trial
$2,297,829Ann Marie Stowe · University Of Kentucky · RF1 · FY2023 · AG
Center for Childhood Obesity Prevention
$2,297,175Judith Lynne Weber · Arkansas Children'S Hospital Res Inst · P20 · FY2023 · GM
Center for Childhood Obesity Prevention
$2,296,429Elisabet Borsheim · Arkansas Children'S Hospital Res Inst · P20 · FY2024 · GM
Lung Vascular Disease in Infants and Children: Mechanisms and Treatment
$2,296,239Kurt R Stenmark · University Of Colorado Denver · P50 · FY2008 · HL
Project 2: Aging Healthy Together: Precision Profiles of Resilience and Risk
$2,295,709Lee Ryan · University Of Arizona · U19 · FY2024 · AG
Advanced genetic engineering technology development
$2,295,000Aron M Geurts · Medical College Of Wisconsin · DP2 · FY2011 · OD
Endophenotypes of Sleep Apnea and Role of Obesity
$2,294,979Allan Ian Pack · University Of Pennsylvania · P01 · FY2010 · HL
Endophenotypes of Sleep Apnea and Role of Obesity
$2,294,979Allan Ian Pack · University Of Pennsylvania · P01 · FY2012 · HL
Endophenotypes of Sleep Apnea and Role of Obesity
$2,294,979Allan Ian Pack · University Of Pennsylvania · P01 · FY2011 · HL
Adaptations to Hypoxia
$2,294,104Kurt R Stenmark · University Of Colorado Denver · P01 · FY2006 · HL
Center for Childhood Obesity Prevention
$2,292,891Judith Lynne Weber · Arkansas Children'S Hospital Res Inst · P20 · FY2022 · GM